Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;17(8):479-496.
doi: 10.1038/s41579-019-0218-1. Epub 2019 Jun 24.

Mechanisms and clinical relevance of bacterial heteroresistance

Affiliations
Review

Mechanisms and clinical relevance of bacterial heteroresistance

Dan I Andersson et al. Nat Rev Microbiol. 2019 Aug.

Abstract

Antibiotic heteroresistance is a phenotype in which a bacterial isolate contains subpopulations of cells that show a substantial reduction in antibiotic susceptibility compared with the main population. Recent work indicates that heteroresistance is very common for several different bacterial species and antibiotic classes. The resistance phenotype is often unstable, and in the absence of antibiotic pressure it rapidly reverts to susceptibility. A common mechanistic explanation for the instability is the occurrence of genetically unstable tandem amplifications of genes that cause resistance. Due to their instability, low frequency and transient character, it is challenging to detect and study these subpopulations, which often leads to difficulties in unambiguously classifying bacteria as susceptible or resistant. Finally, in vitro experiments, mathematical modelling, animal infection models and clinical studies show that the resistant subpopulations can be enriched during antibiotic exposure, and increasing evidence suggests that heteroresistance can lead to treatment failure.

PubMed Disclaimer

References

    1. Hughes, D. & Andersson, D. I. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance. FEMS Microbiol. Rev. 41, 374–391 (2017). - PubMed - PMC
    1. El-Halfawy, O. M. & Valvano, M. A. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin. Microbiol. Rev. 28, 191–207 (2015). A comprehensive and clarifying review of heteroresistance in bacteria. - PubMed - PMC
    1. Alexander, H. E. & Leidy, G. Mode of action of streptomycin on type b Haemophilus influenzae: I. Origin of resistant organisms. J. Exp. Med. 85, 329–338 (1947). - PubMed - PMC
    1. Devi, Y., P. M., P., Thomas, S. & Veeraraghavan, B. Challenges in the laboratory diagnosis and clinical management of heteroresistant vancomycin Staphylococcus aureus (hVISA). Clin. Microbiol. 4, 214 (2015).
    1. Zheng, C. et al. Mixed infections and rifampin heteroresistance among Mycobacterium tuberculosis clinical isolates. J. Clin. Microbiol. 53, 2138–2147 (2015). - PubMed - PMC

Publication types

MeSH terms

Substances

LinkOut - more resources